Latest BPH Stories
Urologix will participate in a BPH hands-on simulation session on Saturday, March 29 at the upcoming “2014 Scottsdale Summit” a multi-institutional, post-graduate conference for general urologists,
According to the initial clinical investigation results at the Department of Urology at The Mikaelian Institute of Surgery in Armenia, men with enlarged prostate have to start benign prostatic
Preliminary results of clinical studies of men with benign prostatic hyperplasia (BPH) conducted at the Department of Urology at The Mikaelian Institute of Surgery have shown that enlarged prostate
Georgetown is First and Only U.S.
UroLift Implant Treatment Included in CMS April 2014 OPPS Update PLEASANTON, Calif., March 13, 2014 /PRNewswire/ -- NeoTract, Inc., today announced that the Centers for Medicare and
Urology Device Market Set to Reach Over $2.6 Billion by 2022, According to Findings from Decision Resources Group BURLINGTON, Mass., March 4, 2014 /PRNewswire/ -- Decision Resources
NICE Interventional Procedure Guidance recommends use of prostatic urethral lift implants under "normal arrangements", the least restrictive classification PLEASANTON, Calif., Jan.
Urologix’ market-leading non-surgical BPH therapies have been well represented at this year’s AUA regional meetings.
Men with mild-to-moderate symptoms of benign prostatic hyperplasia can try a conservative approach called watchful waiting.
Urologix will sponsor the course, “Surviving After Residency – Learning the Business Side of the Practice”, which is designed to bridge the gap between urology residents and successful physician
- A gift; a largess; a gratuity; a present; a dole.